Antonio Ceriello
IRCCS Multimedica of Milan, Milan (Italy)
Speciality : Risk Factors and Prevention
Professor Antonio Ceriello is Head of Diabetes Department at IRCCS MultiMedica, Milan, Italy.Professor Ceriello has published over 450 original papers . His current h-index is 88. Prof. Ceriello has chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, is the President of the European Association for the Study of Diabetes (EASD) Study Group on “Diabetes and CardiovascularDiseases”. He has been Member of the Board for the development of the new “European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “. He also served as Associate Editor of “Diabetes Care” from 2003 to 2011 and Associate Editor of “Diabetic Medicine” from 2005 to 2016. From July 1st 2016 he has been appointed as Editor in Chief of “Diabetes Research and Clinical Practice”, the official IDF journal.
Nebojsa M. Lalic
is a physician, internist and endocrinologist-diabetologist by training who focused his activities on clinical care, research and education in diabetes. Dr Lalic has been engaged in daily clinical practice as a diabetologist for 30 years. He was visiting scientist at Joslin Diabetes Center, Boston, USA, and at present is Director and Head of the Diabetes department at the University Hospital in Belgrade, which is the reference center for diabetes in Serbia, as well as Professor of Internal medicine and Endocrinology and Dean of the Faculty of Medicine, University of Belgrade.
Dr Lalic is chairman of the National Expert Committee for Diabetes and editor of national guidelines in diabetes. He has over 700 diabetes research publications, 80 of them in peer-review journals. He is a full member of the Serbian Academy of Sciences and Arts.
Silvio E. Inzucchi, director of the Yale Medicine Diabetes Center, treats patients who suffer from diabetes as well as pituitary and adrenal disorders. “Endocrinology is fascinating, and we are usually able to help patients improve their quality of life through multidisciplinary care and academic approaches to endocrine conditions,” he says.
Dr. Inzucchi is a professor or medicine (endocrinology) at Yale School of Medicine and the clinical director of the section of endocrinology. In his research, Dr. Inzucchi, studies the cardiovascular effects of diabetes medications and glucose management in the hospital. Named a “top doctor” locally and nationally, Dr. Inzucchi has also received Yale’s David J. Leffell Prize for Clinical Excellence. The prize is given to individuals who demonstrate the highest level of clinical expertise, commitment to teaching and compassion for patients.
He says he has developed an effective personal approach to treating patients, carefully honed over 30 years at Yale.
It includes being on top of the latest advances, but also responding to each patient’s individual needs. “I like to try to draw people out in terms of who they are, what’s important to them, their life experiences and their family. Such an approach resonates with patients because they don’t want to be seen as a patient, they want to be treated as a person,” he says.
Thamer M. Alessa, MD, FACE, CCD
Head, Endocrinology, Diabetes & Metabolism Division, Jaber Al-Ahmad Hospital, Kuwait & Consultant, Endocrine Division, Mubarak Al-Kabeer Hospital, Kuwait
He received the bachelor degree of Medicine and Surgery from the University of Kuwait, Faculty of Medicine.
MARTIN HALUZIK, MD, DSc.
Born August 25, 1970 in Frýdek - Místek, Czech Republic.Married, 2 childrenAFFILIATION: Professor of Internal Medicine and Deputy DirectorDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech RepublicInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine,Charles University and General Faculty Hospital in Prague, Prague, Czech RepublicResearch Fellowship:• Laboratory for Endocrinology&Metabolism, 3rd Department of Medicine, 1st Faculty ofMedicine, Prague, Czech Republic. 1997 - Ph.D. in Endocrinology• Visiting Fellow, Diabetes Branch, NIDDK, NIH, Bethesda, MD, USA - 2000 – 2002 –laboratories of Dr. Marc Reitman and Dr. Derek LeRoith• 2007 – DSc. in Internal MedicineCLINICAL SPECIALIZATION: Diabetes, Endocrinology, Obesity, General internal medicineRESEARCH INTERESTS:• Type 2 diabetes, etiopathogenesis of insulin resistance, endocrine function of adiposetissue and gastrointestinal tract• Cardiovascular and renal complications of diabetes• Etiopathogenesis and treatment of hyperglycemia in critically ill patients• Novel technologies in the treatment of type 1 diabetesGRANTS AND RESEARCH PROJECTS HISTORY:Principal investigator of numerous national grants, country coordinator of 4 EU projects of the 6th a 7thFramework programme (CLINICIP, OLDES, K4CARE, SAFEGUARD)Principal investigator of Investigator initiated trial EXECUTIVE (EXEnatide in Patients UndergoingCoronary Artery Bypass Grafting for Improved glUcose conTrol and hemodynamIc ValuEs) - fundedby Eli Lilly, BMS, Astra Zeneca and IDEAL (Insulin therapy DE-intensification with iGlArLixi) –funded by SanofiSELECTED EDITORIAL BOARDS MEMBERSHIPS:• Co-Editor-in-Chief - Journal of Endocrinology/Journal of Molecular Endocrinology• Field Editor - Physiological Research